{"id":"https://openalex.org/W2189330249","doi":null,"title":"Cost-effective analysis of dual therapy in epilepsy, a study from India","display_name":"Cost-effective analysis of dual therapy in epilepsy, a study from India","publication_year":2011,"publication_date":"2011-01-01","ids":{"openalex":"https://openalex.org/W2189330249","mag":"2189330249"},"language":"en","primary_location":{"id":"mag:2189330249","doi":null,"is_oa":false,"landing_page_url":"http://neurology-asia.org/articles/neuroasia-2011-16(4)-309.pdf","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null},"volume":null,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5078458370","display_name":"Sarita Goyal","orcid":"https://orcid.org/0009-0007-2542-0860","observed_orcids":["https://orcid.org/0009-0007-2542-0860"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sarita Goyal","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0007-2542-0860","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113880684","display_name":"Deepak Goel","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Deepak Goel","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100976174","display_name":"MC Gupta","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"MC Gupta","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5024445828","display_name":"Taruna Sharma","orcid":"https://orcid.org/0000-0002-8017-9199","observed_orcids":["https://orcid.org/0000-0002-8017-9199"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Taruna Sharma","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-8017-9199","affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.3879,"has_fulltext":false,"cited_by_count":4,"citation_normalized_percentile":{"value":0.61696092,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":94},"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10094","display_name":"Epilepsy research and treatment","score":0.9965999722480774,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10094","display_name":"Epilepsy research and treatment","score":0.9965999722480774,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","score":0.0012000000569969416,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T12229","display_name":"Pharmacological Effects and Toxicity Studies","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/2735","display_name":"Pediatrics, Perinatology and Child Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/epilepsy","display_name":"epilepsy","score":0.9819999933242798},{"id":"https://openalex.org/keywords/cost-effectiveness","display_name":"cost-effectiveness","score":0.9160000085830688},{"id":"https://openalex.org/keywords/seizure-frequency","display_name":"seizure frequency","score":0.6639999747276306},{"id":"https://openalex.org/keywords/quality-of-life","display_name":"quality of life","score":0.9779999852180481},{"id":"https://openalex.org/keywords/valproic-acid","display_name":"valproic acid","score":0.9049999713897705},{"id":"https://openalex.org/keywords/lamotrigine","display_name":"lamotrigine","score":0.9990000128746033},{"id":"https://openalex.org/keywords/clonazepam","display_name":"clonazepam","score":0.9580000042915344},{"id":"https://openalex.org/keywords/oxcarbazepine","display_name":"oxcarbazepine","score":0.9990000128746033},{"id":"https://openalex.org/keywords/clobazam","display_name":"clobazam","score":1.0},{"id":"https://openalex.org/keywords/phenobarbital","display_name":"phenobarbital","score":0.8939999938011169},{"id":"https://openalex.org/keywords/phenytoin","display_name":"phenytoin","score":0.9980000257492065},{"id":"https://openalex.org/keywords/qolie-31","display_name":"QOLIE-31","score":0.9129999876022339}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8030201196670532},{"id":"https://openalex.org/C2778802184","wikidata":"https://www.wikidata.org/wiki/Q410346","display_name":"Lamotrigine","level":3,"score":0.7064934372901917},{"id":"https://openalex.org/C2781176495","wikidata":"https://www.wikidata.org/wiki/Q176301","display_name":"Oxcarbazepine","level":4,"score":0.6904739141464233},{"id":"https://openalex.org/C2778186239","wikidata":"https://www.wikidata.org/wiki/Q41571","display_name":"Epilepsy","level":2,"score":0.6567526459693909},{"id":"https://openalex.org/C2779951463","wikidata":"https://www.wikidata.org/wiki/Q7268788","display_name":"Quality of life (healthcare)","level":2,"score":0.6073156595230103},{"id":"https://openalex.org/C2777683783","wikidata":"https://www.wikidata.org/wiki/Q221174","display_name":"Topiramate","level":3,"score":0.5342205166816711},{"id":"https://openalex.org/C2779426884","wikidata":"https://www.wikidata.org/wiki/Q407988","display_name":"Clonazepam","level":2,"score":0.5214121341705322},{"id":"https://openalex.org/C2777907850","wikidata":"https://www.wikidata.org/wiki/Q412164","display_name":"Clobazam","level":3,"score":0.4795791208744049},{"id":"https://openalex.org/C500440147","wikidata":"https://www.wikidata.org/wiki/Q701216","display_name":"Pharmacotherapy","level":2,"score":0.4375573396682739},{"id":"https://openalex.org/C2776738588","wikidata":"https://www.wikidata.org/wiki/Q1567856","display_name":"Pharmacoeconomics","level":2,"score":0.41433778405189514},{"id":"https://openalex.org/C187212893","wikidata":"https://www.wikidata.org/wiki/Q123028","display_name":"Pediatrics","level":1,"score":0.3749315142631531},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.253293514251709},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.250300794839859},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.19883513450622559},{"id":"https://openalex.org/C2779253243","wikidata":"https://www.wikidata.org/wiki/Q410412","display_name":"Carbamazepine","level":3,"score":0.1535838544368744},{"id":"https://openalex.org/C159110408","wikidata":"https://www.wikidata.org/wiki/Q121176","display_name":"Nursing","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:2189330249","doi":null,"is_oa":false,"landing_page_url":"http://neurology-asia.org/articles/neuroasia-2011-16(4)-309.pdf","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9940000176429749,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":28,"referenced_works":["https://openalex.org/W21834069","https://openalex.org/W81540165","https://openalex.org/W1572054254","https://openalex.org/W1923445647","https://openalex.org/W1975482228","https://openalex.org/W1975668741","https://openalex.org/W1979819746","https://openalex.org/W1985094165","https://openalex.org/W1987037102","https://openalex.org/W1987100967","https://openalex.org/W1992601586","https://openalex.org/W1992770589","https://openalex.org/W2004557857","https://openalex.org/W2021074267","https://openalex.org/W2025125752","https://openalex.org/W2031325622","https://openalex.org/W2038351697","https://openalex.org/W2040930801","https://openalex.org/W2046381118","https://openalex.org/W2050019610","https://openalex.org/W2063913361","https://openalex.org/W2064038251","https://openalex.org/W2083404739","https://openalex.org/W2084008102","https://openalex.org/W2087319194","https://openalex.org/W2091397922","https://openalex.org/W2109298743","https://openalex.org/W2259928828"],"related_works":["https://openalex.org/W2766115148","https://openalex.org/W2093375302","https://openalex.org/W2045467310","https://openalex.org/W1972054964","https://openalex.org/W2040930801","https://openalex.org/W2383266445","https://openalex.org/W3080138551","https://openalex.org/W1626687307","https://openalex.org/W2065180064","https://openalex.org/W2468752649"],"abstract_inverted_index":{"Background":[0],"and":[1,20,92,145,157,173,184,219],"Objective:":[2],"For":[3],"improving":[4,220],"overall":[5],"care":[6,60],"in":[7,54,63,104,124,143,159,170,175,177,202,215],"epileptic":[8],"patients,":[9],"careful":[10],"evaluation":[11],"of":[12,17,57,74,135,141,152,155,161],"pharmacotherapy,":[13],"seizure":[14,125,171,217],"control,":[15],"quality":[16,160],"life":[18,142],"(QOL)":[19],"cost":[21,146,154,225],"effectiveness":[22,147],"are":[23,28,207,223],"helpful":[24],"but":[25,222],"such":[26],"data":[27],"relatively":[29],"meagre":[30],"from":[31],"developing":[32],"countries.":[33],"The":[34,108],"present":[35],"study":[36],"was":[37,120,128,148,165],"undertaken":[38],"to":[39,213],"audit":[40],"all":[41,178],"these":[42],"said":[43],"factors":[44],"with":[45,51],"different":[46],"drug":[47],"combinations":[48],"comparing":[49],"older":[50],"newer":[52,214],"drugs":[53,206],"the":[55,191,197],"setting":[56],"a":[58,166],"tertiary":[59],"epilepsy":[61],"hospital":[62],"India.":[64],"Methods:":[65],"Forty":[66],"patients":[67,109],"were":[68,78,110],"divided":[69],"into":[70],"four":[71,179],"treatment":[72],"groups,":[73],"ten":[75],"each":[76],"which":[77],"valproic":[79,84],"acid":[80],"+":[81,89,94],"lamotrigine":[82],"(Group-I),":[83],"acid+":[85],"clonazepam":[86],"(Group-II),":[87],"oxcarbazepine":[88],"clobazam":[90],"(Group-III)":[91],"phenobarbitone":[93],"phenytoin":[95],"(Group-IV),":[96],"based":[97],"on":[98],"most":[99],"commonly":[100],"used":[101],"dual":[102],"therapy":[103],"local":[105],"clinical":[106],"practice.":[107],"followed":[111],"at":[112,181,190],"monthly":[113],"intervals":[114],"for":[115,199],"six":[116],"months.":[117,187],"Effi":[118],"cacy":[119],"assessed":[121,129],"by":[122,130],"reduction":[123,169],"frequency,":[126],"QOL":[127,176],"using":[131],"an":[132],"adapted":[133],"version":[134],"31-":[136],"items":[137],"questionnaire":[138],"QOLIE-31":[139],"(quality":[140],"epilepsy)":[144],"calculated":[149],"as":[150,211],"ratio":[151],"direct":[153],"medicine":[156],"improvement":[158,174,201],"life.":[162],"Results:":[163],"There":[164],"signifi":[167],"cant":[168],"frequency":[172,218],"groups":[180],"2":[182],"nd":[183],"6":[185],"th":[186],"Cost-effectiveness":[188],"analysis":[189],"end":[192],"showed":[193],"that":[194],"group-IV":[195],"paid":[196],"least":[198],"same":[200],"QOL.":[203],"Conclusion:":[204],"Older":[205],"equally":[208],"effi":[209],"cacious":[210],"compared":[212],"controlling":[216],"QOL,":[221],"more":[224],"effective.":[226]},"counts_by_year":[{"year":2023,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":1}],"updated_date":"2025-11-06T04:12:42.849631","created_date":"2016-06-24T00:00:00"}